Profile data is unavailable for this security.
About the company
OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in HKD (TTM)1.32bn
- Net income in HKD317.86m
- Incorporated2021
- Employees1.43k
- LocationOrbusNeich Medical Group Holdings LtdUnits 303 & 305, 3/F Building 20E, Hong Hong KongHKG
- Phone+852 28022288
- Websitehttps://orbusneich.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai HeartCare Medcl Tech Corp Ltd | 378.91m | 48.01m | 1.74bn | 327.00 | 37.03 | 1.41 | 21.16 | 4.59 | 1.24 | 1.24 | 9.93 | 32.47 | 0.2736 | 0.7131 | 3.54 | 1,101,478.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Ethk Labs Inc | 3.48bn | 197.13m | 1.86bn | 877.00 | 9.62 | 0.4796 | 7.66 | 0.5344 | 0.1205 | 0.1205 | 2.13 | 2.42 | 0.536 | 1.06 | 6.84 | 4,035,572.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| Sisram Medical Ltd | 2.70bn | 160.99m | 1.89bn | 1.04k | 11.73 | 0.5179 | 5.76 | 0.6983 | 0.3437 | 0.3437 | 5.77 | 7.78 | 0.549 | 1.55 | 3.90 | 2,662,902.00 | 3.90 | 5.64 | 4.82 | 6.66 | 60.93 | 58.95 | 7.10 | 9.80 | 1.73 | -- | 0.0879 | 28.86 | -2.83 | 15.01 | -20.23 | 3.87 | 41.74 | 2.81 |
| PW Medtech Group Ltd | 955.77m | 165.80m | 1.97bn | 1.36k | 12.17 | 0.454 | 5.43 | 2.07 | 0.1101 | 0.1101 | 0.6354 | 2.95 | 0.1603 | 2.91 | 11.47 | 675,458.80 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
| Guanze Medical Infrm Indstry (Hldng) Ltd | 166.94m | 23.45m | 2.84bn | 58.00 | 121.57 | 9.53 | 86.66 | 17.01 | 0.0246 | 0.0246 | 0.1764 | 0.3136 | 0.5073 | 2.21 | 1.30 | 2,928,732.00 | 7.23 | 9.50 | 8.33 | 12.04 | 36.79 | 41.43 | 14.25 | 13.09 | 5.23 | 51.53 | 0.0544 | 34.79 | -0.2127 | 2.03 | -37.59 | -5.08 | 24.24 | -- |
| OrbusNeich Medical Group Holdings Ltd | 1.32bn | 317.86m | 3.03bn | 1.43k | 9.50 | 0.9484 | 8.36 | 2.30 | 0.3854 | 0.3854 | 1.60 | 3.86 | 0.3919 | 0.9325 | 4.20 | 990,730.90 | 9.48 | 7.59 | 10.29 | 9.02 | 67.91 | 68.61 | 24.19 | 16.07 | 9.95 | -- | 0.0107 | 10.02 | 6.65 | 11.24 | -11.88 | 41.68 | 29.71 | -- |
| MicroTech Medical (Hangzhou) Co Ltd | 498.59m | -31.31m | 3.07bn | 645.00 | -- | 1.39 | -- | 6.16 | -0.0751 | -0.0751 | 1.19 | 5.29 | 0.2015 | 3.65 | 4.02 | 735,387.90 | -1.27 | -4.48 | -1.38 | -4.70 | 48.65 | 48.32 | -6.28 | -39.29 | 8.33 | -- | 0.0154 | -- | 36.48 | 46.13 | 49.51 | -- | 22.22 | -- |
| Jenscare Scientific Co Ltd | 15.19m | -276.95m | 3.29bn | 174.00 | -- | 3.34 | -- | 216.43 | -0.6794 | -0.6794 | 0.0373 | 2.36 | 0.0125 | 0.0508 | -- | 71,983.88 | -23.35 | -- | -24.76 | -- | 88.09 | -- | -1,864.69 | -- | 6.39 | -854.86 | 0.0631 | -- | -- | -- | 52.25 | -- | -- | -- |
| Peijia Medical Ltd | 755.31m | -254.75m | 4.12bn | 1.04k | -- | 1.84 | -- | 5.45 | -0.3851 | -0.3851 | 1.14 | 3.33 | 0.2561 | 1.40 | 17.04 | 721,406.10 | -8.76 | -26.57 | -10.02 | -28.99 | 69.25 | 71.23 | -34.21 | -247.65 | 1.49 | -15.30 | 0.1396 | -- | 39.53 | 101.13 | 42.28 | -- | 83.33 | -- |
| Acotec Scientific Holdings Ltd | 670.68m | 114.15m | 4.32bn | 645.00 | 36.80 | 2.64 | 24.84 | 6.44 | 0.3744 | 0.3744 | 2.23 | 5.21 | 0.3353 | 1.06 | 3.53 | 1,031,822.00 | 5.71 | 0.2467 | 6.45 | 0.289 | 75.23 | 81.33 | 17.02 | 0.7122 | 5.57 | -- | 0.1406 | 0.00 | 12.69 | 33.72 | 260.88 | 17.74 | 83.44 | -- |
Data as of Feb 16 2026. Currency figures normalised to OrbusNeich Medical Group Holdings Ltd's reporting currency: Hong Kong Dollar HKD
0.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 216.50k | 0.03% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 60.50k | 0.01% |
| DFA Australia Ltd.as of 31 Dec 2025 | 27.23k | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
